Harvard Bioscience, Inc. (FRA:HBI)

Harvard Bioscience Revenue

Harvard Bioscience had revenue of $20.59M USD in the quarter ending September 30, 2025, a decrease of -6.28%. This brings the company's revenue in the last twelve months to $87.37M, down -10.60% year-over-year. In the year 2024, Harvard Bioscience had annual revenue of $94.14M, down -16.14%.

• Revenue (ttm): $87.37M
• Revenue Growth: -10.60%
• P/S Ratio: 0.39
• Revenue / Employee: $246.12K
• Employees: 355
• Market Cap: 29.04M EUR

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	94.14M	-18.12M	-16.14%
Dec 31, 2023	112.25M	-1.09M	-0.96%
Dec 31, 2022	113.34M	-5.57M	-4.68%
Dec 31, 2021	118.90M	16.80M	16.46%
Dec 31, 2020	102.10M	-14.08M	-12.12%